What is Onglyza?
Onglyza is an oral diabetes medication prescribed for people with type 2 diabetes. It is a dipeptidyl peptidase-4 inhibitor.
What is the Problem With Onglyza?
Several diabetes medications have been linked to serious side effects in recent years. Complications allegedly caused by diabetes medications such as Actos and Januvia are at issue in hundreds of lawsuits across the country. The FDA took formal action in April, 2015 that should concern patients taking Onglyza. An FDA Advisory Committee voted to require an update to Onglyza’s label specifically warning of the risk of heart failure associated with Onglyza. The committee vote was 14/15 to require this warning on the label. The 15th member voted to remove Onglyza from the market entirely. The Committee also noted that more information is needed regarding the whether Onglyza increases the risk of death from causes other than heart failure. Since this action, the FDA has warned that Onglyza can cause severe, debilitating joint pain. Onglyza may also be linked with pancreatic cancer.
How Often Does Onglyza Cause Heart Failure?
Although additional studies are needed, the FDA Advisory Committee noted that patients taking the class of diabetes medication that includes Onglyza have a 27% increase in the rate of hospitalization for heart failure.
Do I Have an Onglyza Lawsuit?
If you or someone you know developed heart disease, pancreatic cancer, or disabling joint pain while taking Onglyza, you should speak with an Onglyza lawyer. The attorneys at Riley & Jackson are available to discuss your situation with you.